checkpoint inhibitors: parallel management of the disease and immune-related toxicities
Published 6 years ago • 52 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:53
toxicities and new immune checkpoint inhibitors
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
4:27
the role of immune checkpoint inhibitors in mds
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
5:33
cancer immune checkpoint inhibitors
-
51:09
autoimmune encephalitis clinical presentation and management
-
12:05
immune checkpoint inhibitors by dr praveen kr gupta
-
6:31
what are checkpoint inhibitors?
-
3:21
nox2: a potential immune checkpoint for inhibition in aml
-
4:55
checkpoint inhibitor combination approaches for aml/mds: an update
-
1:10
the sensitization of immune checkpoint inhibitors with subsequent chemotherapy in r/r hl
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
4:59
checkpoint inhibitors in aml
-
2:53
immune checkpoint inhibitors in mds: the i4mds consortium
-
1:34
checkpoint inhibitors and their potential role in mm
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:28
checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to allosct for hl
-
2:17
the impact of checkpoint inhibitor-based salvage regimens in patients with r/r hl undergoing autosct
-
1:08
incorporating checkpoint-inhibitors into second-line cll therapy
-
1:58
impact of checkpoint inhibitor-based salvage regimens prior to allosct in r/r chl